You are currently viewing DES in Bifurcation Lesions insight from the ICPS Registry

DES in Bifurcation Lesions insight from the ICPS Registry

EBC - ON DEMAND

DES in Bifurcation Lesions insight from the ICPS Registry

European Bifurcation Club 2007, EBC 2007 – Valencia, Spain

NEW DEVICES, NEW TECHNIQUES

DES in Bifurcation Lesions insight from the ICPS Registry

Author: Thierry Lefevre, MD, ICPS, France

 

STUDY

  • Prospective registry (2003-2005)
  • All consecutive DES patients
  • Provisonal SB T-stenting strategy
  • Clinical follow-up at 6, 12 months and 2 years
  • Angiography in case of ischaemia
  • Aspirin ≥75 mg/d, indefinitely
  • Clopidogrel 75 to 150 mg/d > 2/6 months (Cypher/Taxus)

CONCLUSION

In this large real world prospective multicenter study on bifurcation lesions stenting using a predefined strategy of provisional SB T-stenting, we found that this approach can be used in about90% of cases. We found very promising results up to 2 years.

The risk of stent thrombosis remains acceptablecompared to non bifurcation lesions. The only independant procedural predictor of death is the non use of a provisional SB T-stenting strategy. However, there is probably confounding factors.

 

Download here

Leave a Reply